Quetiapine
- All
- News
-
This New Drug May Help Treat Parkinson's Disease
Using anonymised medical records of patients diagnosed with Parkinson's disease, researchers singled out 676 cases that met the study criteria of having a PD diagnosis and being prescribed pimavanserin, quetiapine (an antipsychotic drug marketed as Seroquel) or both.
-
Unichem Lab Gets US Regulator's Nod For Schizophrenia Tablets
The approval is for the company's tablets in the strengths of 25 mg, 50 mg, 100 mg, 200 mg, 300 mg and 400 mg, it added.
-
Jubilant receives US regulator nod for antipsychotic drug
The abbreviated new drug applications (ANDAs) approval from the US Food and Drug Administration is for Quetiapine Fumarate tablet, generic version AstraZeneca's Seroquel is in strength of 25 mg (base).
-
Lupin, Dr Reddy's, Sun get USFDA nod for mental disorder drug
Three Indian drug majors, Lupin, Dr Reddy's, Sun Pharma have got approvals from the US health regulator to sell generic quetiapine fumarate tablets, used in treating mental disorders, in the American market.
-
This New Drug May Help Treat Parkinson's Disease
Using anonymised medical records of patients diagnosed with Parkinson's disease, researchers singled out 676 cases that met the study criteria of having a PD diagnosis and being prescribed pimavanserin, quetiapine (an antipsychotic drug marketed as Seroquel) or both.
-
Unichem Lab Gets US Regulator's Nod For Schizophrenia Tablets
The approval is for the company's tablets in the strengths of 25 mg, 50 mg, 100 mg, 200 mg, 300 mg and 400 mg, it added.
-
Jubilant receives US regulator nod for antipsychotic drug
The abbreviated new drug applications (ANDAs) approval from the US Food and Drug Administration is for Quetiapine Fumarate tablet, generic version AstraZeneca's Seroquel is in strength of 25 mg (base).
-
Lupin, Dr Reddy's, Sun get USFDA nod for mental disorder drug
Three Indian drug majors, Lupin, Dr Reddy's, Sun Pharma have got approvals from the US health regulator to sell generic quetiapine fumarate tablets, used in treating mental disorders, in the American market.
